Click image to zoom
AstraZeneca Claims COVID-19 Vaccine Has 76 Percent Effectivity After US Trials
A vial of AstraZeneca COVID-19 vaccine is seen at the Military Institute of Medicine in Warsaw, Poland on March 25, 2021. AstraZeneca announced on Monday in a press release that its adenovirus vector-based vaccine demonstrated 79 percent efficacy preventing symptomatic Covid-19 and 100 percent efficacy in preventing death and hospitalization. The data released comes after a public rebuke from the National Institutes of Health concerning how AstraZeneca presented some of its older results showing higher efficacy earlier this week. (Photo by Jaap Arriens/NurPhoto)
Photo Details
| Photo ID | #6558216 |
|---|---|
| Date Taken | |
| Location | N/A |
| Photographer | Jaap Arriens/NurPhoto |
| Category | Human Interest |
| Copyright | © 2026 NurPhoto - Jaap Arriens/NurPhoto |
Related Keywords
astrazeneca
coronavirus
covid
daily life
disease pandemic
doctor
epidemic
health
hospital
lockdown
medication
medicine
needle
nurse
poland
syringe
test
vaccination
vaccine
vial
virus
percent efficacy
higher efficacy
vial of AstraZeneca COVID
symptomatic Covid
adenovirus vector-based vaccine
National Institutes of Health
public rebuke
older results
Military Institute of Medicine
Warsaw
press release
Jaap Arriens
NurPhoto
Poland
week
death
hospitalization
data
2026 NurPhoto. All rights reserved.
This image is the property of NurPhoto and is protected under international copyright laws.
Similar Photos
View All
